In Vivo Effects of Josamycin, Erythromycin, and Placebo Therapy on Nasal Carriage of Staphylococcus aureus
Healthy nasal carriers of Staphylococcus aureus were randomly assigned to one of three treatment regimens: josamycin (1.5 g/day), erythromycin stearate (1.0 g/day), or placebo, each administered orally for 7 days. Quantitative nasal cultures were obtained from each subject at intervals before, durin...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1977
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC351998/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/324389/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.11.3.407 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|